Sponsorship and Indemnity Policy
- All publications arising from studies conducted through the Network will be published under 'The UK Dermatology Clinical Trials Network' followed by the trial name (e.g. 'The UK Dermatology Clinical Trials Network PATCH Study Group').
- An appendix detailing the role of each contributor will be included in any publication.
The appendix will be grouped according to the role of each contributor and only those individuals who have made a substantial contribution to one or more of the following groups will be listed:
- Trial development group and steering group responsible for the conception and design, or analysis and interpretation of data;
- Recruiting group responsible for patient accrual throughout the study. This includes all principal investigators, co-investors and any other members of the site study teams that have made a significant contribution to recruitment;
- Data monitoring committee responsible for overseeing the study and monitoring adverse event rates;
- Writing group responsible for drafting the article or revising it critcally for important intellectual content and final approval of the rversion to be published;
- Other groups as appropriate for the individual study.
3. The Chief Investigator/Guarantor will be corresponding author.
4. The support of the National Co-ordinating Centre for Research Capacity Development (NCC
RCD) in funding the co-ordinating centre will be appropriately acknowledged, plus any
individual study funders.
Sponsorship and Indemnity Policy
All UK DCTN trials have a designated sponsor and appropriate indemnity cover in place. The choice of sponsor for a particular piece of research depends on several factors and is decided at the time of development.
All trials are managed through the co-ordinating centre at the Centre of Evidence Based Dermatology at the University of Nottingham.
Activities supported centrally include:
- Administration and support
- Advice on trial development
- Advertising and fundraising for the network
- Maintenance of the website
- Liaising with recruiting centres
- Maintaining a database of members
- Data management
- Data analysis
- Data monitoring
- Preparing Ethics, Research and Development, and MHRA applications
- Submitting funding applications
- Archiving
- Training/workshops
The Chief Investigator for each trial will take overall responsibility for the design and conduct of the trial.
The Chief Investigator will be expected to fulfil all of the requirements of the chief investigators under the terms of research governance, although some tasks will be delegated to the co-ordinating centre and/or trial managers.
The current remit of the UK DCTN is to answer questions that are important to the NHS through non-industry funded sources, although we plan to develop ways of working with industry colleagues in future. The UK Clinical Research Network (UKCRN) are developing links with industry, see their website at http://www.ukcrn.org.uk/index/industry
